Compounds > wr 1065
Page last updated: 2024-08-26

wr 1065 and Glioma

wr 1065 has been researched along with Glioma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grdina, DJ; Kataoka, Y; Murley, JS; Patel, R1
Calvin, DP; Grdina, DJ; Kataoka, Y; Murley, JS1
Grdina, DJ; Kataoka, Y; Khodarev, NN; Murley, JS; Weichselbaum, RR1
Berens, ME; Dougherty, DV; Doz, F; Rosenblum, ML; Spencer, DR1

Other Studies

4 other study(ies) available for wr 1065 and Glioma

ArticleYear
Cytoprotection by WR-1065, the active form of amifostine, is independent of p53 status in human malignant glioma cell lines.
    International journal of radiation biology, 2000, Volume: 76, Issue:5

    Topics: Amifostine; Cell Survival; Cytoprotection; Dose-Response Relationship, Radiation; Genes, p53; Glioma; Humans; Mercaptoethylamines; Mutation; Radiation-Protective Agents; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2000
Differential activation of nuclear transcription factor kappaB, gene expression, and proteins by amifostine's free thiol in human microvascular endothelial and glioma cells.
    Seminars in radiation oncology, 2002, Volume: 12, Issue:1 Suppl 1

    Topics: Amifostine; Cell Adhesion Molecules; Cells, Cultured; Endothelium, Vascular; Gene Expression; Glioma; Growth Substances; Humans; Mercaptoethylamines; Monokines; NF-kappa B; Radiation Dosage; Radiation-Protective Agents; Superoxide Dismutase; Transcriptional Activation; Tumor Cells, Cultured

2002
Activation of the nuclear transcription factor kappaB (NFkappaB) and differential gene expression in U87 glioma cells after exposure to the cytoprotector amifostine.
    International journal of radiation oncology, biology, physics, 2002, May-01, Volume: 53, Issue:1

    Topics: Amifostine; Chemokine CCL5; Gene Expression Regulation; Genes, myb; Genes, myc; Glioma; Glutathione Transferase; Humans; Interleukin-2 Receptor alpha Subunit; Mercaptoethylamines; NF-kappa B; Oxidation-Reduction; Radiation-Protective Agents; Radiobiology; Receptors, Interleukin; Superoxide Dismutase; Tumor Cells, Cultured

2002
Experimental basis for increasing the therapeutic index of carboplatin in brain tumor therapy by pretreatment with WR compounds.
    Cancer chemotherapy and pharmacology, 1991, Volume: 28, Issue:4

    Topics: Bone Marrow; Bone Marrow Cells; Brain Neoplasms; Carboplatin; Cell Line; Cells, Cultured; Colony-Forming Units Assay; Drug Interactions; Drug Screening Assays, Antitumor; Glioma; Humans; Mercaptoethylamines; Tumor Cells, Cultured

1991